70 results
Page 2 of 4
8-K
EX-99.1
rfc1 udruo41unjwn
10 Aug 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results
6:46am
424B5
lf8r2kan nrmdt
7 Jul 21
Prospectus supplement for primary offering
4:11pm
S-3ASR
x9ow5wtn75uwqeh1text
10 Jun 21
Automatic shelf registration
7:03am
DEF 14A
gcovwuy
23 Apr 21
Definitive proxy
4:05pm
424B5
jfya9 tegpv
1 Apr 21
Prospectus supplement for primary offering
8:15am
8-K
EX-1.1
gb0qtn62c2o0ba7x8nf8
1 Apr 21
Other Events
7:48am
424B7
cy5 w9ifp644pstt
1 Apr 21
Prospectus with selling stockholder info
7:36am
424B7
204aqlu
1 Apr 21
Prospectus with selling stockholder info
7:24am
S-3ASR
EX-4.5
kss t18ejyfb9b
1 Apr 21
Automatic shelf registration
6:08am
S-3ASR
zlgwbo
1 Apr 21
Automatic shelf registration
6:08am
8-K
EX-99.1
km01k vj2
15 Mar 21
Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results
6:45am
8-K
EX-10.1
c7iqmz mv
19 Jan 21
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
6:46am
424B4
4ylyss er
1 Oct 20
Prospectus supplement with pricing info
4:21pm